2.47
price up icon2.92%   0.07
after-market Dopo l'orario di chiusura: 2.50 0.03 +1.21%
loading
Precedente Chiudi:
$2.40
Aprire:
$2.37
Volume 24 ore:
1.01M
Relative Volume:
0.58
Capitalizzazione di mercato:
$289.65M
Reddito:
-
Utile/perdita netta:
$-134.24M
Rapporto P/E:
-1.3955
EPS:
-1.77
Flusso di cassa netto:
$-121.34M
1 W Prestazione:
+0.82%
1M Prestazione:
+21.08%
6M Prestazione:
-51.85%
1 anno Prestazione:
-51.09%
Intervallo 1D:
Value
$2.30
$2.53
Intervallo di 1 settimana:
Value
$2.30
$2.53
Portata 52W:
Value
$1.285
$7.85

Annexon Inc Stock (ANNX) Company Profile

Name
Nome
Annexon Inc
Name
Telefono
(650)-822-5500
Name
Indirizzo
1400 SIERRA POINT PARKWAY, BRISBANE
Name
Dipendente
100
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
ANNX's Discussions on Twitter

Confronta ANNX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ANNX
Annexon Inc
2.47 289.65M 0 -134.24M -121.34M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Annexon Inc Stock (ANNX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-03-01 Aggiornamento JP Morgan Neutral → Overweight
2023-12-21 Aggiornamento BofA Securities Neutral → Buy
2023-10-30 Iniziato Wells Fargo Overweight
2023-05-26 Downgrade BofA Securities Buy → Neutral
2023-05-25 Downgrade JP Morgan Overweight → Neutral
2022-09-16 Iniziato Jefferies Buy
2022-09-09 Iniziato BTIG Research Buy
2021-11-30 Iniziato H.C. Wainwright Buy
2021-09-23 Iniziato Cantor Fitzgerald Overweight
2021-01-26 Iniziato Needham Buy
2020-08-18 Iniziato BofA Securities Buy
2020-08-18 Iniziato Cowen Outperform
2020-08-18 Iniziato JP Morgan Overweight
Mostra tutto

Annexon Inc Borsa (ANNX) Ultime notizie

pulisher
Jun 18, 2025

Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025 - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrop - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

Bank of America Corp DE Sells 137,220 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 17, 2025
pulisher
Jun 17, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Sold by Park Avenue Securities LLC - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Market Highlights: Annexon Inc (ANNX) Ends on a Low Note at 2.49 - DWinneX

Jun 16, 2025
pulisher
Jun 13, 2025

Annexon Inc (ANNX) Stock: A Comprehensive 52-Week Review - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

49,062 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Bought by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Estimates Annexon FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

Annexon Biosciences Holds Annual Stockholders Meeting - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Reduces Stock Holdings in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Sells 49,438 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Grows Stake in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Transcript : Annexon, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 08 - marketscreener.com

Jun 05, 2025
pulisher
Jun 03, 2025

Huntington’s Disease Clinical Trial Pipeline Analysis: 20+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics | DelveInsight - GlobeNewswire Inc.

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Makes New $59,000 Investment in Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Buys 14,475 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Bought by Jane Street Group LLC - Defense World

May 30, 2025
pulisher
May 29, 2025

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference | ANNX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Annexon Biosciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

May 29, 2025
pulisher
May 26, 2025

Nuveen Asset Management LLC Acquires 164,915 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 26, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Invests $177,000 in Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 26, 2025
pulisher
May 25, 2025

Annexon, Inc. (NASDAQ:ANNX) Stock Holdings Raised by Ameriprise Financial Inc. - Defense World

May 25, 2025
pulisher
May 22, 2025

Deutsche Bank AG Acquires 28,448 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 22, 2025
pulisher
May 21, 2025

Annexon, Inc. (NASDAQ:ANNX) Shares Purchased by Northern Trust Corp - Defense World

May 21, 2025
pulisher
May 20, 2025

Annexon reports promising Guillain-Barré treatment results By Investing.com - Investing.com India

May 20, 2025
pulisher
May 19, 2025

Annexon (ANNX) Highlights Promising Results from Tanruprubart Ph - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Annexon reports promising Guillain-Barré treatment results - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

Annexon Showcases Tanruprubart Data Demonstrating Improved Clini - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Annexon Showcases Tanruprubart Data Demonstrating Improved - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting - The Manila Times

May 19, 2025
pulisher
May 19, 2025

New GBS Drug Shows 3X Better Outcomes Than Standard Care in Clinical Trial | ANNX Stock News - Stock Titan

May 19, 2025
pulisher
May 19, 2025

Annexon Inc (NASDAQ: ANNX) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

May 19, 2025
pulisher
May 17, 2025

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 17, 2025
pulisher
May 16, 2025

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) | ANNX Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Annexon Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Annexon Awards $387K Worth of Stock Options to New Hires: Inside the Compensation Package - Stock Titan

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Issues Negative Estimate for Annexon Earnings - Defense World

May 16, 2025
pulisher
May 16, 2025

HC Wainwright Has Lowered Expectations for Annexon (NASDAQ:ANNX) Stock Price - Defense World

May 16, 2025
pulisher
May 15, 2025

Needham & Company LLC Has Lowered Expectations for Annexon (NASDAQ:ANNX) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga

May 14, 2025
pulisher
May 14, 2025

Annexon (ANNX) Receives Revised Price Target from HC Wainwright - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Schonfeld Strategic Advisors LLC Sells 589,091 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World

May 14, 2025
pulisher
May 13, 2025

Cantor Fitzgerald maintains Overweight on Annexon stock By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Annexon (ANNX) Sees Price Target Cut to $14 by H.C. Wainwright | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Annexon Inc Reports Q1 2025 EPS of -$0.37, Missing Estimates; Re - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Annexon (ANNX) Maintains "Buy" Rating Despite Price Target Cut | ANNX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Annexon Biosciences Reports Increased Q1 2025 Losses - TipRanks

May 13, 2025
pulisher
May 12, 2025

Annexon, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Annexon Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025

Annexon Inc Azioni (ANNX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Annexon Inc Azioni (ANNX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Feb 18 '25
Sale
2.97
5,515
16,380
83,814
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Feb 18 '25
Sale
2.91
8,345
24,284
61,237
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Feb 18 '25
Sale
2.95
6,618
19,523
86,579
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Feb 18 '25
Sale
2.92
6,912
20,183
77,770
Love Douglas
PRESIDENT AND CEO
Feb 13 '25
Sale
2.95
5,021
14,812
351,554
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Feb 13 '25
Sale
2.98
1,786
5,322
84,682
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Feb 13 '25
Sale
2.99
1,425
4,261
93,197
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Feb 13 '25
Sale
2.99
1,783
5,331
69,582
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):